PubMed Health⌕ Search

Biomedical subjects

Haresh Kirpalani

Publications and source records attributed to Haresh Kirpalani.

10 recordsLinked to original sources
PubMed2006

The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants.

OBJECTIVE: To determine whether extremely low birth weight infants (ELBW) transfused at lower hemoglobin thresholds versus higher thresholds have different rates of survival or morbidity at discharge. STUDY DESIGN: Infants weighing <1000 g birth weight were randomly assigned within 48 hours of birth to a transfusion algorithm of either low or high hemoglobin transfusion thresholds. The composite primary outcome was death before home discharge or survival with any of either severe retinopathy, bronchopulmonary dysplasia, or brain injury on cranial ultrasound. Morbidity outcomes were assessed, blinded to allocation. RESULTS: Four hundred fifty-one infants were randomly assigned to low (n = 223) or high (n = 228) hemoglobin thresholds. Groups were similar, with mean birth weight of 770 g and gestational age of 26 weeks. Fewer infants received one or more transfusions in the low threshold group (89% low versus 95% high, P = .037). Rates of the primary outcome were 74.0% in the low threshold group and 69.7% in the high (P = .25; risk difference, 2.7%; 95% CI -3.7% to 9.2%). There were no statistically significant differences between groups in any secondary outcome. CONCLUSIONS: In extremely low birth weight infants, maintaining a higher hemoglobin level results in more infants receiving transfusions but confers little evidence of benefit.

Algorithms↗
PubMed2006

In-house, overnight physician staffing: a cross-sectional survey of Canadian adult and pediatric intensive care units.

OBJECTIVE: Physician staffing is an important determinant of patient outcomes following intensive care unit (ICU) admission. We conducted a national survey of in-house after-hours physician staffing in Canadian ICUs. DESIGN: : Cross-sectional survey. SETTING: Canadian adult and pediatric ICUs. PARTICIPANTS: ICU directors. INTERVENTIONS: ICU directors of Canadian adult and pediatric ICUs were surveyed to describe overnight staffing by interns, residents, critical care medicine trainees, clinical assistants, and ICU physicians in their ICUs. MEASUREMENTS AND MAIN RESULTS: Data were collected regarding hospital and ICU demographics and ICU staffing. For ICUs with in-house overnight physicians, we documented physician experience, shift duration, and clinical responsibilities outside the ICU. We identified 98 Canadian ICU directors, of whom 88 (90%) responded. Dedicated in-house physician coverage overnight was reported in 53 (60%) ICUs, including 13 (15%) in which ICU staff physicians stayed in-house overnight. Compared with ICUs without in-house physicians, those with in-house physicians had more ICU beds (15 vs. 8.5, p=.0001) and fewer ICU staff physicians (5 vs. 7, p=.03). For the 271 physicians who provide overnight staffing, the median level of postgraduate experience was 3 yrs (range, <1 yr, >10 yrs); 129 (48%) had <3 months of ICU experience. Most shifts (83%) were >20 hrs long. CONCLUSIONS: In-house overnight physician staffing in Canadian ICUs varies widely. Only a minority of ICUs comply with the 2003 Society of Critical Care Medicine guidelines for adult ICUs recommending continuous in-house staffing by ICU staff physicians. The duration of most ICU shifts raises concern about workload-associated fatigue and medical error. The impact of current nighttime staffing requires further evaluation with respect to patient outcomes.

Adult↗
PubMed2005

Neonatal persistent pulmonary hypertension treated with milrinone: four case reports.

Current standard therapy for persistent pulmonary hypertension of the newborn (PPHN) consists of optimal lung inflation, hemodynamic support and selective vasodilation with inhaled nitric oxide (iNO). However, not all infants will respond. Milrinone, a phosphodiesterase (PDE) III inhibitor, is routinely used in pediatric cardiac intensive care units to improve inotropy and reduce afterload. Although its use in post-operative cardiac failure has been proven in a randomized trial, it has not been reported to be beneficial in PPHN. We report four cases with severe PPHN treated with a combination of iNO and Milrinone. All four cases were unresponsive to therapy including iNO, with a mean oxygenation index (OI) of 40 (standard deviation (SD) 12)) before Milrinone. Substantial improvement in OI (mean of 28; SD 16) was followed by extubation and survival. However, of 4 patients, 2 developed serious intraventricular hemorrhages (IVHs), and 1 had a small IVH. To clarify the risk benefit ratio, of death versus survival with impairment, a randomized controlled trial is needed.

Administration, Inhalation↗
PubMed2004

A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure.

OBJECTIVE: Inhaled nitric oxide (iNO) reduces the use of extracorporeal membrane oxygenation (ECMO)/incidence of death in term and near-term neonates with severe hypoxic respiratory failure. We conducted a randomized, double masked, multicenter trial to determine whether administration of iNO earlier in respiratory failure results in additional reduction in the incidence of these outcomes. METHODS: Neonates who were born at > or =34 weeks' gestation were enrolled when they required assisted ventilation and had an oxygenation index (OI) > or =15 and <25 on any 2 measurements in a 12-hour interval. Infants were randomized to early iNO or to simulated initiation of iNO (control). Infants who had an increase in OI to 25 or more were given iNO as standard therapy. RESULTS: The trial enrollment was halted after 75% of target sample size was reached because of decreasing availability of eligible patients. The 150 infants who were given early iNO and 149 control infants had similar baseline characteristics. Arterial oxygen tension increased by >20 mm Hg in 73% of early iNO and 37% of control infants after study gas initiation. Control infants received standard iNO and deteriorated to OI >40 more often than infants who were given early iNO. The incidence of death (early iNO, 6.7% vs control, 9.4%), ECMO (10.7% vs 12.1%), and their combined incidence (16.7% vs 19.5%) were similar in both groups. CONCLUSION: iNO improves oxygenation but does not reduce the incidence of ECMO/mortality when initiated at an OI of 15 to 25 compared with initiation at >25 in term and near-term neonates with respiratory failure.

Administration, Inhalation↗
PubMed2003

Beyond the complete blood cell count and C-reactive protein: a systematic review of modern diagnostic tests for neonatal sepsis.

OBJECTIVE: To systematically review the accuracy of modern laboratory tests for the diagnosis of serious bacterial infection in newborns. METHODS: The MEDLINE, EMBASE, and Cochrane Library databases were searched using the keywords newborn, infection, sepsis, and diagnosis. We included studies published from 1995 through 2001 that included infants younger than 90 days with proven bacterial growth in a sample from a sterile site. Whenever possible, relevant data were extracted to calculate likelihood ratios (LRs) for whether each test can diagnose a serious bacterial infection. Two independent reviewers selected and reviewed the articles (interobserver agreement, kappa = 0.80). All disagreements were resolved by consensus. RESULTS: Of the 137 citations we retrieved, 37 articles met the inclusion criteria; 17 studies, evaluating 11 different tests, met the highest methodological criteria. The most commonly evaluated test was interleukin 6 (IL-6) level (n = 7 studies). The remaining tests were each evaluated in no more than 3 studies. Positive LRs ranged from 1.5 to infinity. Six individual tests examined in 8 studies had LRs of more than 10 (range, 12.5- infinity ). Combined tests also had a wide range of LRs (3.4-9.9). All studies were performed in single medical centers and had small sample sizes, making recommendations according to gestational age criteria difficult. CONCLUSIONS: We found few methodologically rigorous studies of the accuracy of laboratory tests for the diagnosis of bacterial infection in newborns; in a significant proportion of studies, the accuracy of the tests could not be independently determined because of a lack of adequate data. There was marked heterogeneity in sample selection and cutoff levels for diagnosis of neonatal sepsis. A few tests showed promising accuracy, but there are insufficient data to support their confident use as clinical tools.

Bacteremia↗
PubMed2003

PEEP--a "cheap" and effective lung protection.

Mechanical ventilation is a complex therapy with several different parameters which can be altered. In preterm and term infants, more attention has been paid to the levels of peak inspiratory pressure than to the positive end-expiratory pressure (PEEP). An awareness that lung protection can be conferred by an appropriate level of PEEP has increasingly stimulated a renewed interest in achieving the "best PEEP" strategy. We review the history of the introduction of PEEP therapy, some of the early demonstrations of its potential for mischief, the evidence on what levels of PEEP are appropriate in infants, some data concerning the lung-protective value of PEEP and finally some recent efforts at defining measures to determine the so-called "best PEEP". Some of this work has been performed in adults with the acute respiratory distress syndrome. In newborns, we are regrettably forced to conclude that there is, for the immediate present, no easy substitute for sensible clinical observations coupled with a judicious and cautious adjustment of PEEP. We anticipate that a more logical application of PEEP with individualisation of therapy, based on a pressure-volume relationship, will in future enable targeted tests of PEEP as a lung-protection strategy.

Humans↗
PubMed2002

Evaluating "old" definitions for the "new" bronchopulmonary dysplasia.

OBJECTIVES: To examine the accuracy of different criteria for the diagnosis of bronchopulmonary dysplasia (BPD), based on the final age at which oxygen therapy was stopped, in predicting pulmonary and neurologic outcomes at 18-month corrected age. STUDY DESIGN: Data were collected prospectively on infants with birth weights between 500 and 999 g enrolled in the Trial of Indomethacin Prophylaxis in Preterms (TIPP) who survived to discharge home. Differing postnatal ages and postmenstrual ages at which supplemental oxygen therapy was no longer required formed the criteria for defining BPD. Diagnostic accuracy of each criterion for defining BPD was calculated for both poor pulmonary and poor neurosensory outcomes. RESULTS: The prevalence of poor pulmonary outcome was 54% and of poor neurosensory outcome was 34% in the 956 infants who were eligible for this analysis. Accuracy of different definitions of BPD was limited but greatest when using supplemental oxygen requirement at 36 weeks' postmenstrual age to predict long-term pulmonary outcome (63%) and 40 weeks to predict long-term neurosensory outcome (68%). CONCLUSIONS: Poor pulmonary outcome and poor neurosensory outcome are common late adverse outcomes in this population. BPD as defined by duration of oxygen therapy is a less accurate surrogate currently than in previous eras.

Brain Diseases↗